Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/1999
09/29/1999CN1230218A Imidazolinone herbicide resistant sugar beet plants
09/29/1999CN1230217A Imidazolinone herbicide resistant sugar beet plants
09/29/1999CN1230197A Subunit respiratory syncytial virus vaccine prepn.
09/29/1999CN1229851A Hybridizing tumour cell non-serum culture medium
09/28/1999US5959187 Expression of oxygen-binding proteins in plants
09/28/1999US5959183 Cytoplasmic male sterility DNA factor and utilization thereof
09/28/1999US5959177 Transgenic plants expressing assembled secretory antibodies
09/28/1999US5959176 Plant promoter and utilization thereof
09/28/1999US5959175 Sunflower albumin 5' regulatory region for the modification of plant seed lipid composition
09/28/1999US5959086 The present invention relates to proteins associated with acute pancreatitis and agents for the diagnosis of this disease.
09/28/1999US5959084 Bispecific antibodies, methods of production and uses thereof
09/28/1999US5959080 Bacillus thuringiensis genes encoding nematode-active toxins
09/28/1999US5959079 CREBA isoform
09/28/1999US5959075 Testis-specific insulin homolog polypeptides
09/28/1999US5958892 2-methoxyestradiol-induced apoptosis in cancer cells
09/28/1999US5958880 Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
09/28/1999US5958872 Active survival domains of IGF-IR and methods of use
09/28/1999US5958774 Generally, the invention relates to a method for gene transfer into cells activated from a quiescent state, in particular hematopoietic stem cells, and the cells thus obtained.
09/28/1999US5958767 Engraftable human neural stem cells
09/28/1999US5958765 For producing human monoclonal antibodies which are specific to respiratory syncytial virus and in particular the rsv fusion (f) protein
09/28/1999US5958751 A thermostable alpha-glycosidase derived from various thermococcus, alcaliphilus aedii12ra is disclosed. the enzymes are produced from native or recombinant host cells and can be utilized in the food processing industry.
09/28/1999US5958734 Isolated polynucleotides and polypeptides of the glutamyl trna synthetase family (glus), vectors encoding them, host cells and methods for their production; use to screen for novel antibiotics
09/28/1999US5958731 Cell junction PDZ protein
09/28/1999US5958727 Methods for modifying the production of a polypeptide
09/28/1999US5958726 Polynucleotide sequence of clone h84924 accession number atcc 98028; has signal sequence; for diagnosis and treatment of related diseases
09/28/1999US5958725 Human DP1 homolog
09/28/1999US5958723 DNA encoding prostaglandin receptor DP
09/28/1999US5958711 Contacting a sample from a subject with an agent specific for said complex and determining interaction between said complex and said agent as a determination of said disorder
09/28/1999US5958709 Processes for identifying compounds that bind to the human Y4 receptor
09/28/1999US5958707 Human interleukin-4 antagonist/agonist screens
09/28/1999US5958705 Cytoplasmic modulators of integrin regulation/signaling
09/28/1999US5958699 Hybridization probe comprising polynulceotide encoding polypeptide; for identifying and encoding nucleic acid and amino acid sequences and using them for diagnosis, prevention, and treatment of intestinal diseases including cancer
09/28/1999US5958428 Synthetic compounds and compositions with enhanced cell binding
09/28/1999US5958425 Viral vaccines
09/28/1999US5958424 Recombinant chicken anemia virus particle
09/28/1999US5958422 Containing a foreign peptide insert in the coat protein of the virus; for use in vaccines
09/28/1999US5958412 Administering conjugate of antibody and anti-cancer drug, where in antibody is specific for a33 antigen for promoting colon or gastric cancer regression
09/28/1999US5958405 Human protein tyrosine kinase
09/28/1999US5958404 Grafting cells for treatment of disease and diabetes
09/28/1999US5958400 Isolated polypeptide comprising specified amino acid sequence
09/28/1999CA2187803C Methods of treating disease using sertoli cells and allografts or xenografts
09/28/1999CA2088354C Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies
09/28/1999CA2042447C Control of microsporogenesis by externally inducible promoter sequences
09/28/1999CA1340769C Inducible virus resistance in plants
09/28/1999CA1340766C Selectable marker for development of vectors and transformation systems in plants
09/28/1999CA1340765C Transcription in plants and bacteria
09/28/1999CA1340764C Octopine t-dna promoters
09/26/1999CA2264260A1 Polynucleotide molecules encoding neospora proteins
09/24/1999CA2249660A1 Novel compounds
09/23/1999WO1999047929A1 Development of human monoclonal antibodies and uses thereof
09/23/1999WO1999047921A1 CO-EXPRESSION OF Gia PROTEIN AND Gi PROTEIN COUPLED RECEPTOR TO ENHANCE SIGNAL TRANSDUCTION RESPONSES
09/23/1999WO1999047703A1 Method for producing agents for treating tumour diseases and for immunosuppression
09/23/1999WO1999047691A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses
09/23/1999WO1999047682A1 Adp-glucose transporter complex of the amyloplast
09/23/1999WO1999047681A1 Adp-glucose transporter of the amyloplast
09/23/1999WO1999047678A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same
09/23/1999WO1999047677A2 Polypeptides homologous to vegf and bmp1
09/23/1999WO1999047675A1 Mu-1, member of the cytokine receptor family
09/23/1999WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer
09/23/1999WO1999047673A2 Isolated mammalian membrane protein genes and related reagents
09/23/1999WO1999047670A1 Mammalian sodium channel proteins
09/23/1999WO1999047669A2 Human nucleic acid sequences from tissue of breast tumors
09/23/1999WO1999047662A1 Staphylococcus aureus genes and polypeptides
09/23/1999WO1999047661A2 Production of biofilaments in transgenic animals
09/23/1999WO1999047660A1 Retroviral packaging cell line
09/23/1999WO1999047659A1 Use of human serum resistant vector particles and cell lines for human gene therapy
09/23/1999WO1999047655A2 Human nucleic acid fragments with heightened expression in normal breast tissue
09/23/1999WO1999047649A2 Polymerase chimeras
09/23/1999WO1999047648A2 Medium and method for viral propagation and growth
09/23/1999WO1999047646A1 Processes for improved presentation of antigens by dendritic cells
09/23/1999WO1999047645A1 Process for the production of virus in cell cultures
09/23/1999WO1999047644A1 Keratinocyte stem cells
09/23/1999WO1999047643A1 Selection subtraction approach to gene identification
09/23/1999WO1999047642A2 Development of normal offspring from oocytes injected with freeze-dried spermatozoa
09/23/1999WO1999047641A1 Compositions and methods for gene-based vaccines to provoke t cell responses
09/23/1999WO1999047639A2 Staphylococcus aureus genes and polypeptides
09/23/1999WO1999047565A1 Anti-inositolphosphoglycan monoclonal antibodies
09/23/1999WO1999047564A1 Fas-associated polypeptides
09/23/1999WO1999047557A2 Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins
09/23/1999WO1999047553A2 Bacterial yeal family members as targets for antimicrobial drug design
09/23/1999WO1999047552A2 Genes encoding mlo proteins and conferring fungal resistance upon plants
09/23/1999WO1999047544A1 nrdF
09/23/1999WO1999047540A1 95 human secreted proteins
09/23/1999WO1999047539A1 Thermostable dna polymerase from thermoanaerobacter thermohydrosulfuricus
09/23/1999WO1999047538A1 Cytokine receptor common gamma chain like
09/23/1999WO1999047537A1 Staphylococcus aureus spo0j2: polynucleotide and protein
09/23/1999WO1999047535A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS
09/23/1999WO1999047227A1 Removal of contaminants from biological products
09/23/1999WO1999047169A1 Methods to provoke anti-cancer immune responses
09/23/1999WO1999047166A1 IMMUNOMODULATORY FRAGMENTS OF POLYCLONAL ANTILYMPHOCYTE GLOBULINS (ALGs) AND USES THEREOF
09/23/1999WO1999047163A2 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
09/23/1999WO1999047156A2 Compositions for modulating cell differentiation comprising a lipid and a morphogen
09/23/1999WO1999047147A1 nrdG
09/23/1999WO1999047102A2 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
09/23/1999WO1999046992A1 Induction of immunity against tumor self-antigens
09/23/1999WO1999046988A1 Compositions and methods for antigen-specific vaccination
09/23/1999WO1999046984A1 Compositions and methods for the frozen storage of dendritic cells
09/23/1999WO1999041379A3 Members of the d52 gene family
09/23/1999WO1999041374A3 Human short-chain tnf-receptor family protein
09/23/1999WO1999041369A3 Genetic vaccine vector engineering